Health

Revolutionizing Vaccination: VaxCare’s Breakthrough Strategy Unveiled at NAIIS

2025-05-22

Author: Arjun

VaxCare Unleashes Groundbreaking Vaccine Strategies at National Summit

In a pivotal revelation at the 2025 National Adult and Influenza Immunization Summit (NAIIS), VaxCare, the leading care delivery platform for vaccines, unveiled findings from its groundbreaking study involving nearly 850,000 vaccine administrations. This extensive research showcases innovative co-administration and opportunistic vaccination strategies aimed at boosting vaccine coverage among older adults.

The event, held in Atlanta with over 700 healthcare professionals from more than 130 organizations, spotlighted the crucial discussions surrounding adult influenza immunization and optimal support for CDC-recommended vaccines. Dr. Ruth Carrico, a well-respected family nurse practitioner and adjunct professor at the University of Louisville, spearheaded the presentation for VaxCare, stirring excitement among attendees.

"It’s thrilling to share our in-depth analysis at this significant summit," Dr. Carrico exclaimed. "Having access to such comprehensive data is a rare opportunity for us to provide actionable insights to our peers in the field."

Study Highlights: Leveraging Data for Effective Vaccination

VaxCare’s platform, renowned for its automated vaccine management workflows, served as the backbone for this extensive study, which rigorously analyzed the vaccination landscape during the 2024 respiratory season. The research, titled "Real-World Co-Administration Strategies in People Aged >65," examined the vaccination outcomes for an impressive 638,051 individuals aged 65 and over. The results showcase the effectiveness of combining vaccines, particularly the co-administration of Influenza and COVID-19 vaccines.

Key findings revealed that co-administration is predominantly effective for older adults, with a striking 99.5% of cases involving two vaccines. Notably, the combination of Influenza and COVID-19 vaccines accounted for 67.1% of co-administered doses, and 29.6% included Influenza with Pneumococcal vaccines. Furthermore, opportunistic vaccination often included a mix of respiratory vaccines together with time-sensitive vaccines like Zoster or Tdap.

Changing the Game: VaxCare’s Impact on Vaccination Efficiency

VaxCare’s commitment over the past decade has been to revolutionize the vaccination process for healthcare providers and their patients, partnering with 21,000 providers across 40+ states. Their platform not only simplifies the management and administration of more than four million vaccines annually but also addresses the cost concerns faced by clinics of all sizes.

For more information about how VaxCare is enhancing vaccination strategies across the country, visit www.vaxcare.com.